Background {#Sec1}
==========

Cellular angiofibroma (CAF) is a rare benign mesenchymal lesion with a predilection for the genitourinary region. First described in 1997 \[[@CR1]\], CAF is characterized by a spindle cell component and abundant small- to medium-sized thick-walled vessels \[[@CR2]\]. Cases in males have been previously named "angiomyofibroblastoma-like tumor". Besides two small series, cellular angiofibroma has been described only in isolated case reports, we found only 68 patients with genital CAF (Table [1](#Tab1){ref-type="table"}) \[[@CR3], [@CR4]\]. To date, this last condition still remains a poorly known lesion that needs further investigations to closely define its clinical and pathological features.Table 1Summary of the literature review of vulvar CAF reportedAuthorsYearAgeLocalisationTreatmentFollow-upNucci et al. \[[@CR1]\]199750VulvaComplete excisionNA46Left labia majoraComplete excisionNR, 19 months39Right labiaComplete excisionNR, 12 months49LabiaComplete excisionNAColombat et al. \[[@CR25]\]200137Left labia majoraComplete excisionNALane et al. \[[@CR10]\]200177Left labiaComplete excisionNR, 12 monthsCurry et al. \[[@CR18]\]200137Clitoral hoodNANR, 15 monthsDufau et al. \[[@CR16]\]200253Labia majoraNANADargent et al. \[[@CR9]\]200346Right labial regionNR, 19 months49Lateral part of the clitoris.NR, 7 monthsMcCluggage et al. \[[@CR22]\]200249Left labia majoraComplete excisionReccurence 6 months laterIwasa et al. \[[@CR3]\]200449Labia majoraComplete excisionNA39VulvaNANA46Labia majoraComplete excisionNR, 16 months50VulvaComplete excisionLost42VulvaComplete excisionNR, 75 months42PerineumNANA75VulvaComplete excisionDied of breast cancer41VulvaComplete excisionNR 54 months68VulvaComplete excisionNR, 17 months59Labia majoraComplete excisionNR, 41 month49VulvaNANA37Hymen LocalExcision + positive marginsNR, 24 months38VaginaNANA46VulvaComplete excisionNR, 35 months47Labium majusComplete excisionNR, 44 months47VulvaNANA48Labium majusComplete excisionNR, 8 months24VaginaNANR, 6 months58VaginaComplete excisionNA50VulvaComplete excisionNR, 6 months58VulvaComplete excisionNR, 9 months50VulvaNANAW G McCluggage et al. \[[@CR21]\]200420Not specifiedComplete excisionNR, 20 month,25Posterior vaginal introitusComplete excisionNR, 3 months65Left labia minoraComplete excisionNR, 12 months41Left labia majoraComplete excisionNR, 4 months59Right side of vulvaComplete excisionNR, 18 months32Right labiaComplete excisionNAMicheletti et al. \[[@CR8]\]200551vulvaComplete excisionNR, 4 monthsKerkuta et al. \[[@CR7]\]200531small left labialComplete excisionNR, 10 monthChen et al. \[[@CR11]\]201058VulvaComplete excisionNR, 75 months52Vulva LocalComplete excisionDead of carcinoma34VulvaComplete excisionNA32VulvaComplete excisionNA25VulvaComplete excisionNR, 42 months43VulvaComplete excisionNR, 2 months59VulvaComplete excisionNR, 14 months46VulvaComplete excisionNR, 4 months71VulvaComplete excisionNA39VulvaComplete excisionNR, 7 months46VulvaComplete excisionNAFlucke et al. \[[@CR4]\]201141PerinealComplete excisionNA39Vaginal introitusExcision + positive marginsNR, 75 months50VulvaExcision + positive marginsNR, 55 months51Labium majusMarginal excisionNR, 66 months44Labium majusComplete excisionNA50VulvaExcision + positive marginsNA48VulvaComplete excisionNA42VulvaComplete excisionNA63ClitorisExcision + positive marginsNR, 38 months27Labium majusMarginal excisionNA42VulvaComplete excisionNR, 30 month46Labium majusMarginal excisionNA55VulvaComplete excisionNR, 12 months57VulvaNANR, 6 months47VulvaExcision + positive marginsNA39Vaginal fornixMarginal excisionNAPresent case201537Left labia majoraComplete excisionNR, 20 month*NR* No Recurrence*NA* information not available

We report a case of cellular angiofibroma, for which the clinical diagnosis was Bartholin's glandular cyst.

Case presentation {#Sec2}
=================

A healthy 37-year-old woman consulted for an asymptomatic vulvar nodule of 6 years duration. She was concerned because it had progressively enlarged over the last few months. There was no history of pain or bleeding. Local and colposcopic examinations revealed a 3,5 cm freely mobile non reducible nodule located in the left labia majora. Ultrasonography showed a superficial, well-demarcated, solid soft tissue tumor. A well circumscribed lesion measuring 3 cm in diameter was excised with a rim of normal tissue. Gross examination showed a well circumscribed, solid, whitish, glossy tumor measuring 3× 3 × 2,5 cm. Microscopically, the tumor was well circumscribed, surrounded by a fibrous pseudocapsule. On low-power examination, hypocellular and hypercellular areas, composed of uniform, short spindle-shaped cells, proliferating in an edematous to fibrous stroma (Fig. [1](#Fig1){ref-type="fig"}). Numerous small to medium-sized thick-walled vessels were also seen (Fig. [2](#Fig2){ref-type="fig"}). Mature adipocytes were noted in the periphery in small clusters. There was no necrosis and few or no mitotic figures (Fig. [3](#Fig3){ref-type="fig"}). Immunohistochemical staining was positive for vimentin, CD34 (Fig. [4](#Fig4){ref-type="fig"}), focally for actin, and negative for protein S-100, and desmin. These findings are consistent with the diagnosis of cellular angiofibroma. At 14 months postoperatively, the patient is doing well with no signs of recurrence.Fig. 1low-power view showing uniform, short spindle-shaped cellsFig. 2Numerous small to medium-sized with thick and hyalinized wallsFig. 3Bland spindle cells with uniform nuclei and pale indistinct cytoplasmFig. 4tumour cells exhibiting diffuse positivity with CD34

Discussion {#Sec3}
==========

Tumors primarily arising from the vulvo-vaginal area are relatively rare and they include soft tissue specific and non-specific tumors, as well as a spectrum of fibro-epithelial tumors \[[@CR5], [@CR6]\]. Cellular angiofibroma is an uncommon benign mesenchymal neoplasm, originally described in the genital region, and occurs equally in both genders \[[@CR4]\]. A marked predilection for the vulva is observed \[[@CR2]\], our review of the literature yielded 68 cases reported, involving the female genital tract (Table [1](#Tab1){ref-type="table"}). Women are affected most often in the fifth decade, whereas males are mainly in the seventh decade \[[@CR3]\]. Clinically, cellular angiofibroma is often mistaken for a Bartholin gland, labial, or submucosal cyst \[[@CR7]\].

Etiopathologically, some authors suggested that these lesions are stem cell--derived, with a capacity for adipose and myofibroblastic differentiation in accordance with the influence of hormones, microenvironments, cytokines and growth factors \[[@CR8]\].

Histologically, CAF is typically well circumscribed, composed of two principal components: bland spindle cells and prominent small to medium-sized vessels with mural hyalinization \[[@CR3]\]. The spindle cells are arranged in short intersecting fascicles lying between short bundles of wispy collagen \[[@CR9]\]. Hypocellular areas can be seen, often associated with stromal edema or hyalinization. Typically, significant pleomorphism and abnormal mitoses were absent \[[@CR3]\]. The accompanying blood vessels tend to be thick-walled and even hyalinized \[[@CR10]\]. Mature individual or small clusters of adipocytes can be present, most often located in the periphery of the lesion \[[@CR2], [@CR3]\]. Fletcher et al. recently have reported a study of 13 cases of cellular angiofibroma with atypia and sarcomatous transformation \[[@CR11]\]. The sarcomatous component can show variable features (atypical lipomatous tumor, pleomorphic liposarcoma, and pleomorphic sarcoma). This phenomenon seems not to predispose to recurrence based on limited clinical follow-up available \[[@CR2], [@CR11]\].

Immunohistochemically, the tumor cells consistently are vimentin positive \[[@CR9]\]. The expression of CD34 is seen in 60 % \[[@CR3]\]. Characteristically, they do not express S-100 protein, actin, desmin, or EMA, although a discrete staining for the last three markers has been reported \[[@CR3], [@CR9]\]. Lastly, the tumor cells have been found to be estrogen (ER) and progesterone receptor (PR) positive. However, the significance of the positive estrogen and progesterone receptors in CAF is unknown \[[@CR7]\]. In fact, a subset of mesenchymal cells of the distal female genital tract normally expresses estrogen and progesterone receptor and, the neoplastic cells arising from the vulva, may also show immunoreactivity for ER and/or PR \[[@CR12]\]. Thus, ER or PR immunoreactivity cannot be used to distinguish CAF and its histological mimics \[[@CR13]\]

No specific chromosomal abnormality is found in CAF, although cytogenetic analysis revealed, in a few reported cases, the loss of RB1 and FOXO1A1 genes due to the deletion of the 13q14 region \[[@CR14]\]. This typical loss of genetic material is also shared by myofibroblastoma \[[@CR15]\].

CAF, myofibroblastoma and angiomyofibroblastoma are usually considered as specific soft tissue tumors of the vulvo-vaginal area \[[@CR16]\]. These tumors may show overlapping morphological, immunohistochemical and cytogenetic features, and thus differential diagnosis is mandatory \[[@CR17], [@CR15]\].

Clinically, the age of onset of CAF occurs approximately 10 years later in life than aggressive angiomyxoma, myofibroblastoma and angiomyofibroblastoma \[[@CR18]\]. Histologically, aggressive angiomyxoma is poorly circumscribed, typically infiltrates adjacent soft tissue, and characterized by being composed of relatively uniform spindle cells, embedded in a myxoid matrix \[[@CR10]\]. AMF is a benign tumor which belongs to the category of the "stromal tumors of the lower female genital tract", together with cellular angiofibroma and myofibroblastoma \[[@CR19]\]. It is characterized by the presence of multinucleate cells and epithelioid or plasmacytoid cells which tend to aggregate around blood vessels which are thin-walled \[[@CR21]\]. However recent cytogenetic analyses have shown that only CAF and myofibroblastoma are genetically related lesions because angiomyofibroblastoma lacks 13q14 deletion \[[@CR20]\].

Myofibroblastoma is composed of ovoid- to spindle- or stellate-shaped cells, arranged in a variety of architectural patterns and set in a finely collagenous stroma. Hyalinized blood vessels are a diagnostic clue helpful in distinguishing cellular angiofibroma from myofibroblastoma \[[@CR15]\].

Based on morphological, immunohistochemical and cytogenetic analyses, it has been postulated that CAF and myofibroblastoma of the lower female genital tract are closely related lesions that form a continuous spectrum of a single entity with different morphologic presentations, likely arising from a common precursor mesenchymal cell \[[@CR19]\].

Desmin seems to be a discriminating marker, as aggressive angiomyxoma, myofibroblastoma and angiomyofibroblastoma are positive for this antibody \[[@CR3], [@CR15]\].

Other neoplasms that are not specific to the vulva, such as solitary fibrous tumour, spindle cell lipoma, smooth muscle tumours, nerve sheath tumours, and perineurioma, also enter into the differential diagnosis \[[@CR22]\].

Spindle cell lipoma is composed of brightly, eosinophilic ropy and refractile stromal collagen bands with fewer capillary-sized thin-walled vessels, compared with palely eosinophilic and wispy collagen fibers associated with numerous thick-walled vessels in CAF \[[@CR3], [@CR18]\]. Solitary fibrous tumor (SFT) can be differentiated by the presence of thin-walled branching vascular pattern that may be described as hemangiopericytoma-like vessels, and dense collagen bundles \[[@CR12], [@CR23]\]. SFT shows positivity for CD34, CD99, bcl-2, and ER and/or PR, and negativity for SMA and desmin \[[@CR24]\].

Other mesenchymal lesions (schwannoma, perineurioma and leiomyoma) can be ruled out in accordance with the histology and immunohistochemistry \[[@CR8]\].

CAF behaves in a benign fashion and local excision with clear margins is the treatment of choice. This lesion shows no tendency for metastasis based on the limited clinical follow-up available \[[@CR2], [@CR3], [@CR7]\]. However, there is one case of recurrent CAF, reported by McCluggage et al., in which a 49-year-old woman had recurrent swelling develop at the site of the previous excision 6 months later \[[@CR22]\]. Our patient is well without evidence of local recurrence 20 months after excision.

Conclusions {#Sec4}
===========

CAF represents a rare distinct clinico-pathological condition, that pathologists should be aware of morphological variation (Atypia and Sarcomatous transformation) to prevent diagnostic errors and therefore an aggressive therapy. As far as we are aware, no case of metastatic CAF has been described.
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